Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens.

Authors:
Alaseem AM.

Journal:
Saudi Pharm J

Publication Year: 2023

DOI:
10.1016/j.jsps.2023.101790

PMCID:
PMC10561124

PMID:
37818252

Journal Information

Full Title: Saudi Pharm J

Abbreviation: Saudi Pharm J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Generative AI and AI-assisted technologies in the writing process During the preparation of this work, the author used ChatGPT and Quillbot in order to enhance the language, which involves rewriting particularly complex sentences to ensure greater clarity. After using these tools, the author reviewed and edited the content as needed and take full responsibility for the content of the publication. Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-RG23083)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025